Search
for
Sort by
Research 30 of 61
- Evaluation of Serum UL16 Binding Protein 3 in Patients with Tinea capitis
- Genetics of Alopecia
- ULBP3: a marker for alopecia areata incognita
- Recent Advances in the Pathogenesis of Autoimmune Hair Loss Disease Alopecia Areata
- Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences
- A new path in defining light parameters for hair growth: Discovery and modulation of photoreceptors in human hair follicle
- Retinoids Putting the “A” in Alopecia
- Integrative analysis of rare copy number variants and gene expression data in alopecia areata implicates an aetiological role for autophagy
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- Efficacy of tofacitinib in treatment of alopecia universalis in two patients
- Alopecia Areata
- Epidemiology and burden of alopecia areata: a systematic review
- Regenerative Medicine of Epidermal Structures
- An Overview of Alopecias
- Alopecia areata
- Lichen Planopilaris and Frontal Fibrosing Alopecia as Model Epithelial Stem Cell Diseases
- The pathogenesis of alopecia areata
- Diagnosis and Management of Alopecia in Children
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity
- Fractional Laser-assisted Hair Regrowth and Microneedling for the Treatment of Alopecia Areata: A Review
- Genome-wide association study in alopecia areata implicates both innate and adaptive immunity
- Trichodynia Revisited
- A perspective on predictive markers of alopecia
- SIRT1 downregulation provokes immune-inflammatory responses in hair follicle outer root sheath cells and may contribute to development of alopecia areata
- The correlation between corona virus disease 2019 and alopecia areata: a literature review
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Frontiers in alopecia areata pathobiology research
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway